Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
At the BioFuture 2024 conference held in New York in November, Seema Kumar, the CEO of Cure, described women’s health as something that has been directed at the “bikini area.” That “bikini” bias ...
The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.
In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...
Genetic technology in medicine has evolved to the point where it is now being used to improve care and outcomes for ...
Leerink Partners analyst Thomas Smith has reiterated their bullish stance on IRON stock, giving a Buy rating yesterday. Thomas Smith has given ...
The Warren Alpert Medical School held its 18th annual Academic Symposium Wednesday afternoon. The symposium was the largest ...
1d
Researchers at the University of Alberta looked at conversations between pharmacists and patients before and after an ...
MUI FITNESS US (English) on MSN1d
Team Sports: Muscle Injuries Are the Most Common Among Soccer Players"The most frequent injuries in soccer players, more than 75%, are muscular, contrary to what was thought to be knee and ankle ...
The National Academies of Sciences, Engineering, and Medicine are private ... Published proceedings record the presentations ...
A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback